European Archives - Page 1083 of 1228 - European Medical Journal

EMJ

Computer Model Simulations Offer Treatment Target for Kidney Disease

VIRTUAL tissue technology has discovered two types of cysts in polycystic kidney disease, providing researchers with the potential to develop a new…

EMJ

Immune System Gene Linked to Increased Risk of Kidney Disease

VARIATION in the copy numbers of a gene involved in the innate immune system has been associated with an increased risk of the immunoglobulin A (IgA)…

Acelity To Offer New Gelling Fiber Advanced Wound Dressing

San Antonio, July 28, 2016 – Acelity, a global advanced wound care and regenerative medicine company, announced today that BIOSORB™ Gelling Fiber…

Introducing EMJ Hematology 4.1

United Kingdom, July 28, 2016: Welcome to EMJ Hematology. This edition provides a wide selection of peer-reviewed articles exploring the emerging issues…

Biosimilars: Shaping the Future of Haematology

Prof Robin Foà opened the symposium by highlighting how improving healthcare and an ageing population are increasing the burden on healthcare resources…

Evidence-Based Transfusion Medicine for Coagulopathy of Chronic Liver Disease

Patients with chronic liver disease variably exhibit abnormalities of coagulation related to decreased synthesis of coagulation proteins. This results in…

Review of the 21st European Hematology Association Congress 2016

The city of Copenhagen has been voted the go-to place for holiday makers in Denmark, and from the 9th of June and the 4 days that followed, it was…

Advances in the Treatment of Non-Hodgkin’s Lymphoma: Exploring New Frontiers

A recent symposium at the European Hematology Association (EHA) congress, chaired by Prof Eva Kimby, explored the changing paradigms in the treatment of…

Management of Superficial Vein Thrombosis

Superficial vein thrombosis (SVT), indicating thrombosis of the superficial vein system, is less well-studied than deep vein thrombosis (DVT) because it…

GBT440, a Novel Sickle Haemoglobin Polymerisation Inhibitor, Increases Haemoglobin Oxygen Affinity and Results in a Rapid Improvement in Haemolysis and Anaemia

GBT440 is a novel, small molecule haemoglobin oxygen affinity modifier. In vitro data has shown that by increasing sickle haemoglobin (HbS) oxygen…